Vaxcyte, Inc.
Clinical trials sponsored by Vaxcyte, Inc., explained in plain language.
-
Major trial tests Next-Gen pneumonia shot for seniors
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine called VAX-31 that aims to protect against more strains of bacteria that cause pneumonia and other serious infections. It will enroll 4,000 healthy adults aged 50 and older to compare the safety and immune response of VAX-31 against two existin…
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:15 UTC
-
New vaccine aims to boost protection against pneumonia in older adults
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine called VAX-31 to see if it is safe and how well it boosts the immune system against bacteria that cause pneumonia and other serious infections. It will involve 720 healthy adults aged 50 and older who have already received a standard pneumonia …
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:14 UTC
-
New vaccine combo tested to shield older adults from pneumonia and flu
Prevention Recruiting nowThis study is testing if a new vaccine (VAX-31) designed to prevent pneumococcal disease (like pneumonia) is safe and works well when given at the same time as the seasonal flu shot. It will involve about 1300 healthy adults aged 50 and older who have never had a pneumococcal vac…
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: Prevention
Last updated Mar 13, 2026 15:05 UTC